RBN-3143
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-150207-5MG | 5 mg | 347,00 | Add | |
| HY-150207-1ML | 10 mM * 1 mL | 380,00 | Add | |
| HY-150207-10MG | 10 mg | 502,00 | Add | |
| HY-150207-25MG | 25 mg | 1'044,00 | Add | |
| HY-150207-50MG | 50 mg | 1'664,00 | Add | |
| HY-150207-100MG | 100 mg | 2'723,00 | Add |
* CHF, excl. 7.7% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
RBN-3143 is a potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM. RBN-3143 inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines. RBN-3143 can be used in research of lung inflammation.
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Inflammation/Immunology, Cell Cycle/DNA Damage, Epigenetics |
| Format | Solubility: DMSO : 12.5 mg/mL (27.81 mM; ultrasonic and warming and heat to 80°C) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.24% |
| Molecular Formula | C22H28FN3O4S |
| Molecular Weight | 449.54 |
| CAS-Number | 2360853-16-1 |
| Storage Conditions | Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room temperature |
| Material Safety Data Sheet | Download PDF |
